CD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected Patients.

• Prif Awduron: Vivian I Avelino-Silva (Awdur), Karina T Miyaji (Awdur), Peter W Hunt (Awdur), Yong Huang (Awdur), Marisol Simoes (Awdur), Sheila B Lima (Awdur), Marcos S Freire (Awdur), Helio H Caiaffa-Filho (Awdur), Marisa A Hong (Awdur), Dayane Alves Costa (Awdur), Juliana Zanatta C Dias (Awdur), Natalia B Cerqueira (Awdur), Anna Shoko Nishiya (Awdur), Ester Cerdeira Sabino (Awdur), Ana M Sartori (Awdur), Esper G Kallas (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Public Library of Science (PLoS), 2016-12-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

BACKGROUND:HIV-infected individuals have deficient responses to Yellow Fever vaccine (YFV) and may be at higher risk for adverse events (AE). Chronic immune activation-characterized by low CD4/CD8 ratio or high indoleamine 2,3-dioxygenase-1 (IDO) activity-may influence vaccine response in this popul...